Brief: JCR Pharmaceuticals Plans To Start Clinical Trial In Japan In First Half Of FY24

Medipal Holdings

02/07/2024 12:38

July 2 (Reuters) - JCR Pharmaceuticals Co Ltd  4552.T :
    * MEDIPAL AND JCR ANNOUNCE COMPLETION OF CLINICAL TRIAL
NOTIFICATION PROCESS IN JAPAN FOR PHASE I/II STUDY OF JR-446 FOR
MUCOPOLYSACCHARIDOSIS TYPE IIIB
    * JCR PHARMACEUTICALS CO LTD - PLAN TO START CLINICAL TRIAL
IN
JAPAN IN FIRST HALF OF FY2024 (APRIL TO SEPTEMBER)

Source text for Eikon:  ID:nBw12lqq4a 
Further company coverage:  4552.T 

 ((Reuters.Briefs@thomsonreuters.com;))